Cargando…
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
INTRODUCTION: In the present study we evaluated changes in the B cell phenotype in peripheral blood and bone marrow (BM) of patients with rheumatoid arthritis (RA) following anti-CD20 treatment using rituximab. METHODS: Blood and BM samples were obtained from 37 patients with RA prior to rituximab t...
Autores principales: | Rehnberg, Maria, Amu, Sylvie, Tarkowski, Andrej, Bokarewa, Maria I, Brisslert, Mikael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745807/ https://www.ncbi.nlm.nih.gov/pubmed/19686595 http://dx.doi.org/10.1186/ar2789 |
Ejemplares similares
-
Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment
por: Rehnberg, Maria, et al.
Publicado: (2010) -
Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment
por: Magnusson, Mattias, et al.
Publicado: (2010) -
Suppressed diversity of survivin splicing in active rheumatoid arthritis
por: Turkkila, Minna, et al.
Publicado: (2015) -
Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis
por: Bokarewa, Maria, et al.
Publicado: (2005) -
Phenotype and Function of CD25-Expressing B Lymphocytes Isolated from Human Umbilical Cord Blood
por: Amu, Sylvie, et al.
Publicado: (2011)